Should Dramani/Delba be taken before or after meals?

Delamanid is an oral anti-tuberculosis (MDR-TB) drug that is recommended to be taken with food in clinical practice to improve the bioavailability of the drug. This means that taking the drug with or immediately after a meal can increase drug absorption and bring the blood concentration to a more stable level, thus enhancing the anti-tuberculosis activity of the drug. For patients with multidrug-resistant tuberculosis, adequate drug absorption is crucial to the efficacy of the entire course of treatment. Because the MDR-TB treatment cycle is long and the medication is complex, insufficient drug absorption may lead to a decrease in efficacy or even the risk of drug resistance.

In practical applications, patients usually need to fix the medication time to minimize daily fluctuations in blood drug concentration, thereby ensuring the continued stability of the antibacterial effect. At the same time, food intake can also relieve gastrointestinal discomfort that may occur when oral delamanid is administered, such as mild nausea or stomach discomfort, and improve patients' tolerance and compliance with long-term treatment. Clinical studies have shown that regular meal and medication habits can significantly reduce the number of missed or incorrect doses of medication, which is an important guarantee for controlling the failure rate of MDR-TB treatment and the spread of drug resistance.

The dosage and administration regimen of delamanid vary among patients of different ages and weights, so when taking it with food, it needs to be adjusted according to the guidance of a doctor. Elderly patients or patients with digestive system diseases should choose the appropriate meal type and medication time under the advice of their doctor to reduce the occurrence of adverse reactions. Generally speaking, the medication strategy of taking it with meals not only conforms to the pharmacokinetic properties of delamanid, but also provides patients with a safer and more convenient long-term treatment experience, which helps to improve the cure rate of multi-drug-resistant tuberculosis. Delamanid is not only an important drug in the treatment of multi-drug-resistant tuberculosis, but also provides patients with a safe and scientific treatment plan through standardized use and individualized management.

Reference: https://go.drugbank.com/drugs/DB11637